Medial prefrontal cortex Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats

被引:33
|
作者
Terzian, Ana Luisa B. [1 ,2 ]
dos Reis, Daniel Gustavo [3 ]
Guimares, Francisco S. [3 ,4 ]
Correa, Fernando M. A. [3 ]
Resstel, Leonardo B. M. [3 ,4 ]
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
[2] Univ Munich, Grad Sch Syst Neurosci, Munich, Germany
[3] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, BR-14049900 Sao Paulo, Brazil
[4] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, BR-14049900 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Contextual fear; TRPV1; receptors; Prefrontal cortex; Cardiovascular system; Rats; CARDIOVASCULAR-RESPONSES; REVERSIBLE INACTIVATION; ENDOCANNABINOID SYSTEM; SYNAPTIC-TRANSMISSION; EMOTIONAL RESPONSES; INFRALIMBIC CORTEX; PRELIMBIC CORTEX; ANXIETY; MODULATION; LESIONS;
D O I
10.1007/s00213-013-3211-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Contextual fear is evoked by re-exposing an animal to an environment that has been previously paired with an aversive or unpleasant stimulus. It can be assessed by freezing and cardiovascular changes such as increase in mean arterial pressure and heart rate. A marked increase in neuronal activity is associated with contextual fear conditioning, especially in limbic structures involved with defense reactions, such as the ventral portion of medial prefrontal cortex. Given the fact that transient receptor potential vanilloid type 1 (TRPV1) receptors could be involved in the expression of defensive behavior, the present work tested the hypothesis that TRPV1 manipulation in the ventromedial prefrontal cortex (vMPFC) modulates the expression of contextual conditioned fear. Male Wistar rats received bilateral microinjections into the vMPFC of the TRPV1 receptor antagonists capsazepine (1, 10, and 60 nmol/200 nL) or 6-iodonordihydrocapsaicin (3 nmol/200 nL), and the TRPV1 agonist capsaicin (1 nmol/200 nL) preceded by vehicle or 6-iodonordihydrocapsaicin before re-exposure to the experimental chamber for 10 min, 48 h after conditioning in two different protocols distinct by their aversiveness. Both antagonists reduced the freezing and cardiovascular responses in the high aversive protocol. Capsaicin caused an increase in fear-associated responses that could be blocked by 6-iodonordihydrocapsaicin. Our results indicate that TRPV1 receptors located in the vMPFC have a tonic involvement in the modulation of the expression of contextual fear conditioning.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 50 条
  • [41] Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer
    Han, Gwan Hee
    Chay, Doo Byung
    Nam, Sanghee
    Cho, Hanbyoul
    Chung, Joon-Yong
    Kim, Jae-Hoon
    CANCER GENOMICS & PROTEOMICS, 2020, 17 (03) : 309 - 319
  • [42] Unique Responses are Observed in Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and TRPV1) Co-Expressing Cells
    Sadofsky, Laura R.
    Sreekrishna, Koti T.
    Lin, Yakang
    Schinaman, Renee
    Gorka, Kate
    Mantri, Yogita
    Haught, John Christian
    Huggins, Thomas G.
    Isfort, Robert J.
    Bascom, Charles C.
    Morice, Alyn H.
    CELLS, 2014, 3 (02) : 616 - 626
  • [43] In vitro characterization of the thermoneutral transient receptor potential vanilloid-1 (TRPV1) inhibitor GRTE16523
    Damann, Nils
    Bahrenberg, Gregor
    Stockhausen, Hannelore
    Habermann, Christopher J.
    Lesch, Bernhard
    Frank-Foltyn, Robert
    Lee, Jeewoo
    Ann, Jihyae
    Christoph, Thomas
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 871
  • [44] Contribution of transient receptor potential vanilloid 1 (TRPV1) channel to cholinergic contraction of rat bladder smooth muscle
    Sharopov, Bizhan R.
    Philyppov, Igor B.
    Yeliashov, Semen I.
    Sotkis, Ganna V.
    Danshyna, Anastasiia O.
    Falyush, Oksana A.
    Shuba, Yaroslav M.
    JOURNAL OF PHYSIOLOGY-LONDON, 2024, 602 (15): : 3693 - 3713
  • [45] Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies
    Omari, Sofia A.
    Geraghty, Dominic P.
    Khalafallah, Alhossain A.
    Venkat, Pooja
    Shegog, Yvette M.
    Ragg, Scott J.
    de Bock, Charles E.
    Adams, Murray J.
    MEDICAL ONCOLOGY, 2022, 39 (05)
  • [46] Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue
    Sánchez, MG
    Sánchez, AM
    Collado, B
    Malagarie-Cazenave, S
    Olea, N
    Carmena, MJ
    Prieto, JC
    Díaz-Laviada, I
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 515 (1-3) : 20 - 27
  • [47] The Combination of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) is an Effective Prognostic Biomarker in Cervical Cancer
    Han, Gwan Hee
    Chay, Doo Byung
    Nam, Sanghee
    Cho, Hanbyoul
    Chung, Joon-Yong
    Kim, Jae-Hoon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (03) : 214 - 223
  • [48] Changes in vanilloid receptor 1 (TRPV1) expression following lingual nerve injury
    Biggs, James E.
    Yates, Julian M.
    Loescher, Alison R.
    Clayton, Nick M.
    Boissonade, Fiona M.
    Robinson, Peter P.
    EUROPEAN JOURNAL OF PAIN, 2007, 11 (02) : 192 - 201
  • [49] Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands
    Kim, Myeong Seop
    Ki, Yooran
    Ahn, Song Yeon
    Yoon, Suyoung
    Kim, Sung-Eun
    Park, Hyeung-Geun
    Sun, Wei
    Son, Karam
    Cui, Minghua
    Choi, Sun
    Pearce, Larry V.
    Esch, Timothy E.
    DeAndrea-Lazarus, Ian A.
    Blumberg, Peter M.
    Lee, Jeewoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (01) : 382 - 385
  • [50] TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications
    Avelino, Antonio
    Cruz, Francisco
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 373 (04) : 287 - 299